Commercializing Vascepa, the first and only pure EPA omega-3 fatty acid approved to lower triglyceride levels in adults. Presented (+) data from REDUCE-IT CV Outcomes trial at AHA. 2019 guidance of $380-420M, or 66-83% higher y/y.
1430 Route 206
Bedminster, NJ 07921
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Solebury Trout Management Access: SF 2020
San Francisco, CA, United States,
January 13 –
January 16, 2020
Stock Market Data
Market Data copyright © 2019 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by